Uqh 1,4-bis-hemi-succinate

Uqh 1,4-bis-hemi-succinate has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Sep 1, 2026: “Enhanced Extracellular Matrix Synthesis-Related Responses Induced by Ubiquinol-10 Derivatives in Human Dermal Fibroblasts”.

Intervention

1 paper studies it2 findingsUpdated

See all 1 papers on uqh 1,4-bis-hemi-succinate

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: Fukuoka University
  • Cells1

What did studies of uqh 1,4-bis-hemi-succinate find?

2

Studies of uqh 1,4-bis-hemi-succinate measured 2 outcomes: COL1A1 and senescence-associated secretory phenotype (SASP).

COL1A1

upin human cells1

1 study
  1. Uqh 1,4-bis-hemi-succinate increases COL1A1 in NHDFs.

    “upregulated ECM components including COL1A1, elastin, and hyaluronic acid”

    Cellsin NHDFsdermis100 μM48 h

    Enhanced Extracellular Matrix Synthesis-Related Responses Induced by Ubiquinol-10 Derivatives in Human Dermal Fibroblasts

    BioFactors (Oxford, England)

More on COL1A1

Senescence-associated secretory phenotype (SASP)

downin human cells1

1 study
  1. Uqh 1,4-bis-hemi-succinate decreases senescence-associated secretory phenotype (SASP) in NHDFs.

    “suppressed SASP factors, and upregulated ECM components including COL1A1, elastin, and hyaluronic acid”

    Cellsin NHDFsdermis100 μM48 h

    Enhanced Extracellular Matrix Synthesis-Related Responses Induced by Ubiquinol-10 Derivatives in Human Dermal Fibroblasts

    BioFactors (Oxford, England)

More on Senescence-associated secretory phenotype (SASP)

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 01 paper in 12 months